TINIDAZOLE

Post-LOESM

tinidazole

Mission Therapeutics

ANDAORALTABLET

Approved

Oct 2013

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

Pharmacologic Class:

Nitroimidazole Antimicrobial

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (5)

NCT07088419Phase 2Recruiting

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

Started Jul 2025

40 enrolled

Mycoplasma GenitaliumNon-gonococcal Urethritis (NGU)

NCT00510614Phase 1Completed

Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study

Started Oct 2007

37 enrolled

Bacterial Vaginosis

NCT00322465Phase 2Completed

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

Started Nov 2006

305 enrolled

Urethritis

NCT00229216Phase 3Completed

Treatment of Bacterial Vaginosis With Oral Tinidazole

Started Jan 2005

200 enrolled

Bacterial Vaginosis

NCT00334633Phase 4Completed

Treatment of Bacterial Vaginosis (BV) With Tinidazole

Started Nov 2004

593 enrolled

Bacterial Vaginosis

Worked on TINIDAZOLE at Mission Therapeutics? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.